Advertisement
Screener

Codiak BioSciences, Inc. Forms 3, 4 and 5: Warrants

Codiak BioSciences, Inc. Forms 3, 4 and 5: Warrants

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 4 rows, 4 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

  • 2022-09-15: Reporting owner Flagship V VentureLabs Rx Fund, L.P. | Flagship Ventures Fund V General Partner LLC | Flagship Ventures Fund V, L.P. | AFEYAN NOUBAR; Form 4; Security Warrants to purchase Common Stock; Transaction P Open market or private purchase of non-derivative or derivative security.
  • 2022-09-15: Reporting owner Flagship V VentureLabs Rx Fund, L.P. | Flagship Ventures Fund V General Partner LLC | Flagship Ventures Fund V, L.P. | AFEYAN NOUBAR; Form 4; Security Warrants to purchase Common Stock; Transaction P Open market or private purchase of non-derivative or derivative security.
  • 2022-09-13: Reporting owner GILLIS STEVEN; Form 4; Security Warrant (Right to Buy); Transaction P Open market or private purchase of non-derivative or derivative security.
  • 2022-09-13: Reporting owner ARCH Venture Fund VIII Overage, L.P. | ARCH Venture Fund VIII, L.P. | BYBEE CLINTON | ARCH Venture Partners VIII, LLC | CRANDELL KEITH | NELSEN ROBERT | ARCH Venture Partners VIII, L.P.; Form 4; Security Warrant (Right to Buy); Transaction P Open market or private purchase of non-derivative or derivative security.
Transaction dateReporting ownerFormSecurityTransactionSharesPricePrice that dayFiling
2022-09-15Flagship V VentureLabs Rx Fund, L.P. | Flagship Ventures Fund V General Partner LLC | Flagship Ventures Fund V, L.P. | AFEYAN NOUBAR
10% Owner | 10% Owner | 10% Owner | 10% Owner
4Warrants to purchase Common Stock
Derivative · Indirect · By Flagship Ventures Fund V, L.P.
P Open market or private purchase of non-derivative or derivative security+722,590
722,590 owned after
$1.88
exercise price
2022-09-16
2022-09-15Flagship V VentureLabs Rx Fund, L.P. | Flagship Ventures Fund V General Partner LLC | Flagship Ventures Fund V, L.P. | AFEYAN NOUBAR
10% Owner | 10% Owner | 10% Owner | 10% Owner
4Warrants to purchase Common Stock
Derivative · Indirect · By Flagship V VentureLabs Rx Fund, L.P.
P Open market or private purchase of non-derivative or derivative security+210,743
210,743 owned after
$1.88
exercise price
2022-09-16
2022-09-13GILLIS STEVEN
Director
4Warrant (Right to Buy)
Derivative · Indirect · See footnotes
P Open market or private purchase of non-derivative or derivative security+5,000,000
5,000,000 owned after
$1.88
exercise price
2022-09-15
2022-09-13ARCH Venture Fund VIII Overage, L.P. | ARCH Venture Fund VIII, L.P. | BYBEE CLINTON | ARCH Venture Partners VIII, LLC | CRANDELL KEITH | NELSEN ROBERT | ARCH Venture Partners VIII, L.P.
10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner
4Warrant (Right to Buy)
Derivative · Direct
P Open market or private purchase of non-derivative or derivative security+5,000,000
5,000,000 owned after
$1.88
exercise price
2022-09-15